Cannell Capital - Q1 2023 holdings

$517 Million is the total value of Cannell Capital's 90 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

 Value Shares↓ Weighting
SWKH  SWK HLDGS CORP$17,112,148
+1.2%
958,1270.0%3.31%
-2.9%
AMRK  A-MARK PRECIOUS METALS INC$2,672,069
-0.2%
77,1160.0%0.52%
-4.3%
GBLI  GLOBAL INDEMNITY GROUP LLC$2,214,842
+20.8%
78,6800.0%0.43%
+15.7%
NTIP  NETWORK-1 TECHNOLOGIES INC$1,150,054
-2.3%
534,9090.0%0.22%
-6.3%
MQ  MARQETA INC$1,093,697
-25.2%
239,3210.0%0.21%
-28.5%
WINA  WINMARK CORP$704,946
+35.9%
2,2000.0%0.14%
+29.5%
TTP  TORTOISE PIPELINE & ENERGY F$671,929
-4.3%
26,1400.0%0.13%
-8.5%
TYG  TORTOISE ENERGY INFRA CORP$633,276
-7.5%
21,5400.0%0.12%
-11.6%
YNDX  YANDEX N V$487,7790.0%341,1040.0%0.09%
-4.1%
PMD  PSYCHEMEDICS CORP$392,668
+7.0%
74,7940.0%0.08%
+2.7%
SSKN  STRATA SKIN SCIENCES INC$372,251
+34.0%
351,6110.0%0.07%
+28.6%
CVR  CHICAGO RIVET & MACH CO$341,364
+3.8%
11,4860.0%0.07%0.0%
GTX  GARRETT MOTION INC$333,210
+0.5%
43,5000.0%0.06%
-4.5%
ELS  EQUITY LIFESTYLE PPTYS INC$223,879
+3.9%
3,3350.0%0.04%0.0%
DMLP  DORCHESTER MINERALS LP$112,073
+1.2%
3,7000.0%0.02%0.0%
ESP  ESPEY MFG & ELECTRS CORP$107,831
+42.6%
5,3250.0%0.02%
+40.0%
 VIGIL NEUROSCIENCE INC$78,751
-21.7%
8,0440.0%0.02%
-25.0%
GANX  GAIN THERAPEUTICS INC$59,628
+54.0%
12,3710.0%0.01%
+50.0%
OVID  OVID THERAPEUTICS INC$58,360
+38.7%
22,6200.0%0.01%
+37.5%
 OMEGA THERAPEUTICS INC$56,881
+5.6%
9,4330.0%0.01%0.0%
 XILIO THERAPEUTICS INC$53,969
+17.8%
17,0250.0%0.01%
+11.1%
DGICB  DONEGAL GROUP INCcl b$45,120
-7.6%
3,0000.0%0.01%
-10.0%
BNR  BURNING ROCK BIOTECH LTDsponsored ads$45,643
+24.9%
16,2430.0%0.01%
+28.6%
ADAG  ADAGENE INCads$42,047
+9.4%
28,9980.0%0.01%0.0%
CYT  CYTEIR THERAPEUTICS INC$35,825
+10.3%
19,6840.0%0.01%0.0%
GRPH  GRAPHITE BIO INC$35,055
-26.2%
14,3080.0%0.01%
-30.0%
KEQU  KEWAUNEE SCIENTIFIC CORP$38,225
-3.4%
2,4820.0%0.01%
-12.5%
RICK  RCI HOSPITALITY HLDGS INC$35,958
-16.1%
4600.0%0.01%
-22.2%
AUTL  AUTOLUS THERAPEUTICS PLCspon ads$30,976
-3.2%
16,8350.0%0.01%0.0%
GBIO  GENERATION BIO CO$33,402
+9.4%
7,7680.0%0.01%0.0%
LVTX  LAVA THERAPEUTICS NV$29,805
-52.6%
17,9550.0%0.01%
-53.8%
 TSCAN THERAPEUTICS INC$30,799
+35.5%
14,6660.0%0.01%
+20.0%
ANGN  ANGION BIOMEDICA CORP$23,305
-28.5%
40,1810.0%0.01%
-28.6%
GRCL  GRACELL BIOTECHNOLOGIES INCsponsored ads$26,596
-19.1%
14,2990.0%0.01%
-28.6%
 IO BIOTECH INC$23,614
-18.5%
12,5940.0%0.01%
-16.7%
FIXX  HOMOLOGY MEDICINES INC$22,622
-18.3%
21,9630.0%0.00%
-33.3%
 PARDES BIOSCIENCES INC$21,294
-21.9%
16,1320.0%0.00%
-20.0%
 ADAGIO THERAPEUTICS INC$15,179
-20.0%
12,6490.0%0.00%
-25.0%
OMIC  SINGULAR GENOMICS SYSTEMS IN$17,238
-39.8%
14,2460.0%0.00%
-50.0%
GOEDWS  1847 GOEDEKER INC*w exp 06/02/202$178
+23.6%
1,7990.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

About Cannell Capital

Cannell Capital is a well-known investment firm that specializes in small-cap stocks. The company was founded in 1992 by J. Carlo Cannell, who serves as the CEO and Chief Investment Officer. Cannell Capital has a reputation for being an activist investor, meaning that they take an active role in the companies they invest in, often pushing for changes in management or strategy.

One of the key figures at Cannell Capital is the COO, James A. Mitarotonda. Mitarotonda has been with the company since 1993 and is known for his expertise in corporate governance and shareholder activism. He has been involved in a number of high-profile proxy battles, including one with the restaurant chain Denny's in 2010.

Cannell Capital has a diverse portfolio of investments, with a focus on small-cap companies in the technology, healthcare, and consumer goods sectors. The company has a long-term investment strategy, often holding onto stocks for several years. This approach has led to some impressive returns for the firm's investors.

While Cannell Capital is known for its activism, the company also has a reputation for being a responsible investor. They take environmental, social, and governance (ESG) factors into account when making investment decisions, and have been recognized for their commitment to sustainability.

Overall, Cannell Capital is a respected player in the world of small-cap investing, with a track record of success and a commitment to responsible investing practices.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BUILD-A-BEAR WORKSHOP INC37Q1 20237.0%
NETWORK-1 TECHNOLOGIES INC34Q1 20230.8%
A-MARK PRECIOUS METALS INC30Q1 20230.5%
BERKSHIRE HATHAWAY INC DEL28Q1 20202.1%
BERKSHIRE HATHAWAY INC DEL26Q3 20191.6%
HERITAGE CRYSTAL CLEAN INC25Q1 20236.5%
SANDRIDGE ENERGY INC25Q4 20224.5%
THESTREET INC24Q1 20193.2%
WEYERHAEUSER CO MTN BE24Q3 20221.8%
SERVICESOURCE INTL LLC23Q2 20203.2%

View Cannell Capital's complete holdings history.

Latest significant ownerships (13-D/G)
Cannell Capital Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Neuronetics, Inc.March 23, 20233,127,81911.0%
AUDIOEYE INCFebruary 13, 2023818,7257.1%
Fathom Holdings Inc.February 13, 20231,012,8835.9%
Inspired Entertainment, Inc.February 13, 20231,749,8266.8%
North American Construction Group Ltd.February 13, 20231,943,2197.0%
PowerFleet, Inc.February 13, 20232,106,3125.8%
SPORTSMAN'S WAREHOUSE HOLDINGS, INC.February 13, 20233,322,6248.8%
TILE SHOP HOLDINGS, INC.February 13, 20232,453,3275.5%
TrueCar, Inc.February 13, 20235,573,3326.3%
VIA optronics AGFebruary 13, 20231,693,1867.5%

View Cannell Capital's complete significant-ownership history.

Latest filings
TypeFiled
42023-06-01
13F-HR2023-05-15
SC 13G/A2023-04-17
SC 13G/A2023-04-17
SC 13D/A2023-04-05
SC 13D/A2023-03-23
42023-03-20
42023-03-15
42023-03-09
13F-HR2023-02-14

View Cannell Capital's complete filings history.

Compare quarters

Export Cannell Capital's holdings